Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Overexpression of the MRE11-RAD50-NBS1 (MRN) complex in rectal cancer correlates with poor response to neoadjuvant radiotherapy and prognosis
Authors
Keywords
DNA damage response, MRE11-RAD50-NBS1 complex, Rectal cancer, Prognosis, Biomarkers, Neoadjuvant radiotherapy
Journal
BMC CANCER
Volume 18, Issue 1, Pages -
Publisher
Springer Nature America, Inc
Online
2018-09-03
DOI
10.1186/s12885-018-4776-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictive and Prognostic Molecular Biomarkers for Response to Neoadjuvant Chemoradiation in Rectal Cancer
- (2017) Delphine Dayde et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Early Postoperative Low Expression of RAD50 in Rectal Cancer Patients Associates with Disease-Free Survival
- (2017) Vincent Ho et al. Cancers
- High Expression of MRE11–RAD50–NBS1 Is Associated with Poor Prognosis and Chemoresistance in Gastric Cancer
- (2016) BOLAG LTAN et al. ANTICANCER RESEARCH
- Targeting Rad50 sensitizes human nasopharyngeal carcinoma cells to radiotherapy
- (2016) Lihong Chang et al. BMC CANCER
- MRE11 and ATM Expression Levels Predict Rectal Cancer Survival and Their Association with Radiotherapy Response
- (2016) Vincent Ho et al. PLoS One
- DNA damage response – A double-edged sword in cancer prevention and cancer therapy
- (2015) Hui Tian et al. CANCER LETTERS
- Rectal and colon cancer: Not just a different anatomic site
- (2015) K. Tamas et al. CANCER TREATMENT REVIEWS
- New Perspectives on Predictive Biomarkers of Tumor Response and Their Clinical Application in Preoperative Chemoradiation Therapy for Rectal Cancer
- (2015) Nam Kyu Kim et al. YONSEI MEDICAL JOURNAL
- The radiosensitivity index predicts for overall survival in glioblastoma
- (2015) Kamran A. Ahmed et al. Oncotarget
- Neoadjuvant Radiotherapy for Rectal Cancer: Meta-analysis of Randomized Controlled Trials
- (2013) Nuh N. Rahbari et al. ANNALS OF SURGICAL ONCOLOGY
- Differences in Survival between Colon and Rectal Cancer from SEER Data
- (2013) Yen-Chien Lee et al. PLoS One
- Expression of TIP60 (tat-interactive protein) and MRE11 (meiotic recombination 11 homolog) predict treatment-specific outcome of localised invasive bladder cancer
- (2012) Jens R. Laurberg et al. BJU INTERNATIONAL
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Identification of Mre11 as a Target for Heat Radiosensitization
- (2011) Joseph R. Dynlacht et al. RADIATION RESEARCH
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
- (2010) Stephen B. Edge et al. ANNALS OF SURGICAL ONCOLOGY
- MRE11 Expression Is Predictive of Cause-Specific Survival following Radical Radiotherapy for Muscle-Invasive Bladder Cancer
- (2010) A. Choudhury et al. CANCER RESEARCH
- Arrhenius relationships from the molecule and cell to the clinic
- (2009) W. C. Dewey INTERNATIONAL JOURNAL OF HYPERTHERMIA
- Systems Biology Modeling of the Radiation Sensitivity Network: A Biomarker Discovery Platform
- (2009) Steven Eschrich et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Corrected structure of mirin, a small-molecule inhibitor of the Mre11–Rad50–Nbs1 complex
- (2009) Kristen M Garner et al. Nature Chemical Biology
- The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy
- (2008) J. Lindebjerg et al. Colorectal Disease
- A forward chemical genetic screen reveals an inhibitor of the Mre11–Rad50–Nbs1 complex
- (2008) Aude Dupré et al. Nature Chemical Biology
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started